Novartis Japan Sets Up Prevention Committee, Cuts Salaries
This article was originally published in PharmAsia News
Swiss Novartis Pharma Boss David Epstein commented to reporters in Tokyo on the Diovan scandal recently, admitting that the company lacked an internal monitoring system for clinical trials.
You may also be interested in...
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
Erectile dysfunction drug sildenafil, plus treatments for skin conditions such as eczema, are among a bounty of Rx-to-OTC switches approved in Switzerland.